Inombolo yeCas: 224785-91-5 Ifomula yeMolekyuli:C23H33ClN6O4S
Indawo yokunyibilika | 214-216°C |
Ukuxinana | N / A |
ixesha lokugcina | Umoya ongaphakathi, 2-8°C |
ukunyibilika | N / A |
umsebenzi wamehlo | N / A |
Imbonakalo | Mhlophe ukuya kwi-Off-White Cyrstalline |
Ubunyulu | ≥98% |
yayiyi-arhente yesibini ukuthengiswa kwaye yayine-advanteji yokuba ixesha layo lokuqala alizange lincitshiswe ngokusela iyeza kwisisu esipheleleyo.Ngamaxesha e-30 anamandla njenge-inhibitor ye-PDE5 (ithetha i-IC50, i-3.9 nM) kune-sildenafil kunye namaxesha e-10 anamandla ngaphezu kwe-tadalafil, ngokukhetha okukhulu (> amaxesha angama-1,000) kwi-PDE5 yabantu kune-PDE2 yabantu, i-PDE3, kunye ne-PDE4 kunye ukukhetha okuphakathi (> amaxesha angama-80) kwi-PDE1.I-PDE inhibitory selectivity kunye ne-in vitro kunye ne-vivo potency ye-PDE5 inhibitor entsha.ivimbele ngokukodwa i-hydrolysis ye-cGMP nge-PDE5, kunye ne-IC50 ye-0.7 nM (sildenafil 6.6 nM).I-IC50 ye-PDE1 yayiyi-180 nM, ye-PDE6 11 nM, kunye ne-PDE2, i-PDE3 kunye ne-PDE4 ngaphezu kwe-1,000 nM.
Uhlobo olukhethiweyo lwe-phsphodiesterase 5 (PDE5) inhibitor
Ugqirha ucebisa ngokusetyenziswa